Assessment of Cyclosporine Serum Concentrations on the Incidence of Acute Graft Versus Host Disease Post Hematopoietic Stem Cell Transplantation

Abstract

Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative treatment option for hematological disorders. Cyclosporine (CsA) is one of the major immunosuppressive agents for the prophylaxis against graft versus host disease (GvHD).

Description

Keywords

Citation

URI

Endorsement

Review

Supplemented By

Referenced By